ロード中...
Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice
INTRODUCTION: Erythropoietin promotes myoblast proliferation and inhibits fibrosis, thus it could impede the pathogenesis of muscle degenerative diseases. However, its stimulation of erythropoiesis limits its use as a therapeutic. An erythropoietin analog, carbamylated erythropoietin (C-EPO), retain...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3057654/ https://ncbi.nlm.nih.gov/pubmed/21171099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.21785 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|